Yaseen Kady, PA-C

Yaseen Kady practices at Odyssey ASC Endoscopy Center in Irvine, California.

Yaseen Kady's NPI, 1053962233, was assigned on September 27, 2019. Yaseen Kady holds California license 57249.

Yaseen Kady's primary practice is Odyssey ASC Endoscopy Center, at 22 Odyssey, Suite 175, Irvine, CA 92618. The practice phone is (949) 654-8963.

Yaseen Kady's primary practice is Odyssey ASC Endoscopy Center in Irvine, California. Yaseen Kady is also affiliated with Hoag Hospital Newport Beach. The medical group on file is SCKE Health. Dmand AI also links Yaseen Kady to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yaseen Kady practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Yaseen Kady's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Yaseen Kady is licensed in California.

Dmand AI lists acute skin infection, ankle or foot injury, anxiety, chronic kidney disease, conjunctivitis, contact dermatitis, diabetic emergency and enlarged prostate among the conditions Yaseen Kady treats.

CMS data shows 4,175 Medicare services from Yaseen Kady across 49 procedure codes in 2024, for 213 Medicare patients. Medicare paid $112,631 for them.

CMS counts 213 Medicare patients who saw Yaseen Kady in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yaseen Kady's median patient age at 66, with 52% women.

In 2024, Yaseen Kady wrote 1,973 Medicare Part D claims for 280 patients. 60% of them were for generic drugs. CMS names the drug for 1,387 of them, across 47 drugs with 11 or more claims each, at $530,480 in total drug cost. In 2023, CMS named 1,209 claims across 44 drugs.

Yaseen Kady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Yaseen Kady as offering telehealth.

CMS Open Payments shows 792 general payments to Yaseen Kady from 56 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 85% of the total. Travere Therapeutics, Inc. paid the most, $4,092.